Cell therapy workflow: integrated solutions from collection to delivery
Chimeric antigen receptor (CAR)-modified T cells have been gaining use for treatment of hematological malignancies. The patient journey from vein-to-vein is a complex process, from harvesting patient blood to characterization and quality control of the finalized product. The process requires an array of products, instrumentation, equipment and regulatory compliant infrastructure to ensure an efficient workflow. View this infographic to discover how integrated solutions streamlining the five key steps in the CAR-T therapy workflow, from collection to delivery, can optimize your production output.
This content was supplied by Thermo Fisher Scientific.